Long-term cardiac pathology in individuals with mild initial COVID-19 illness

[1]  Guohui Fan,et al.  6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.

[2]  Matthew W. Martinez,et al.  2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play , 2022, Journal of the American College of Cardiology.

[3]  Deepak L. Bhatt,et al.  Cardiac involvement in the long-term implications of COVID-19 , 2021, Nature Reviews Cardiology.

[4]  H. Bartsch,et al.  Long COVID in a prospective cohort of home-isolated patients , 2021, Nature Medicine.

[5]  C. Esopenko,et al.  Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection , 2021, JAMA cardiology.

[6]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[7]  E. Nagel,et al.  Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV. , 2021, JACC. Cardiovascular imaging.

[8]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[9]  David A. Drew,et al.  Attributes and predictors of long COVID , 2021, Nature Medicine.

[10]  S. Villapol,et al.  More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis , 2021, Research square.

[11]  T. Grist,et al.  Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. , 2021, JAMA cardiology.

[12]  P. Sengupta,et al.  High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19 , 2020, JACC: Cardiovascular Imaging.

[13]  Jeremy S. Brown,et al.  ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 , 2020, Thorax.

[14]  F. Callard,et al.  How and why patients made Long Covid , 2020, Social Science & Medicine.

[15]  S. Rizzo,et al.  Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study , 2020, European heart journal.

[16]  Benjamin S. Glicksberg,et al.  Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[17]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[18]  Kipp W. Johnson,et al.  Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection , 2020, Journal of the American College of Cardiology.

[19]  M. Endres,et al.  The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 , 2020, European Respiratory Journal.

[20]  E. Nagel,et al.  Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[21]  E. Nagel,et al.  CMR in Pericardial Diseases - an Update , 2020, Current Cardiovascular Imaging Reports.

[22]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.

[23]  E. Nagel,et al.  CMR in Nonischemic Myocardial Inflammation: Solving the Problem of Diagnosing Myocarditis or Still Diagnostic Ambiguity? , 2020, JACC. Cardiovascular imaging.

[24]  Eike Nagel,et al.  Towards standardized postprocessing of global longitudinal strain by feature tracking – OptiStrain CMR-FT study , 2019, BMC Cardiovascular Disorders.

[25]  E. Nagel,et al.  5035Comparative assessment of diagnostic algorithms of myocardial inflammation by endomyocardial biopsy and tissue mapping by CMR against high-sensitive troponin in viral myocarditis , 2019, European Heart Journal.

[26]  Colin Berry,et al.  Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. , 2019, The New England journal of medicine.

[27]  E. Nagel,et al.  High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus , 2018, Annals of the rheumatic diseases.

[28]  M. Mayr,et al.  Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction , 2018, European heart journal cardiovascular Imaging.

[29]  Stefan K. Piechnik,et al.  Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort , 2017, Journal of Cardiovascular Magnetic Resonance.

[30]  G. Mitchell,et al.  Influence of Vascular Function and Pulsatile Hemodynamics on Cardiac Function , 2015, Current Hypertension Reports.

[31]  E. Nagel,et al.  Aortic Stiffness and Interstitial Myocardial Fibrosis by Native T1 Are Independently Associated With Left Ventricular Remodeling in Patients With Dilated Cardiomyopathy , 2014, Hypertension.

[32]  C. Catalano,et al.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.

[33]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[34]  Tobias Schaeffter,et al.  Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study , 2013, Journal of Cardiovascular Magnetic Resonance.

[35]  G. Mitchell,et al.  Left ventricular responses to acute changes in late systolic pressure augmentation in older adults. , 2013, American journal of hypertension.

[36]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[37]  E. Fleck,et al.  Gender-Specific Differences in Myocardial Deformation and Aortic Stiffness at Rest and Dobutamine Stress , 2012, Hypertension.

[38]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[39]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[40]  Z. Daniil,et al.  The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. , 2008, Respiratory medicine.

[41]  A. Skanes,et al.  A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. , 2006, The Canadian journal of cardiology.

[42]  L. Kuller,et al.  Vascular Stiffness in Women With Systemic Lupus Erythematosus , 2001, Hypertension.

[43]  H. Aretz.  Myocarditis: the Dallas criteria. , 1987, Human pathology.

[44]  Elen,et al.  Native T1 and ECV of Noninfarcted Myocardium and Outcome in Patients With Coronary Artery Disease , 2018 .

[45]  M. Frenneaux,et al.  Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. , 2007, Progress in cardiovascular diseases.

[46]  V. Regitz-Zagrosek,et al.  Role of gender in heart failure with normal left ventricular ejection fraction. , 2007, Progress in cardiovascular diseases.